Summary
On March 25, 2020, in response to the COVID-19 pandemic, Bill C-13 received Royal Assent. Among
other things, Bill C-13 amends the Patent Act to permit
compulsory licensing to respond to a "public health emergency
that is a matter of national concern".
More specifically, Part 12 of Bill C-13 amends the Patent
Act to permit the Government of Canada, upon application to
the Commissioner of Patents, to make, construct, use and sell a
patented invention to the extent it is necessary to respond to a
public health emergency.
Bill C-13 indicates that the relevant patentee is to be paid any
amount the Commissioner considers to be "adequate remuneration
in the circumstances, taking into account the economic value of the
authorization and the extent to which they make, construct, use and
sell the patented invention". Bill C-13 explicitly provides
that the authorized use, sale or construction of the patented
invention, in relation to a public health emergency, does